Clinical Trials
Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced that it has dosed...
Clinical Trials
TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19
TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, announced the launch of Project Covalence, a turnkey...
Clinical Trials
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed...
Clinical Trials
Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients
Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19. The...
Clinical Trials
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment
Junshi Biosciences , a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology company,...
Clinical Trials
Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans
Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.
This investigational medicine,...
Clinical Trials
LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, is expanding its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.